Comparison of effect of 2-methy-3-piperidinopyrazine on target symptoms of anergic schizophrenics.
D006801:Humans; D008996:Monoamine Oxidase Inhibitors; D010880:Piperidines; D012559:Schizophrenia
D008996:Monoamine Oxidase Inhibitors; D010880:Piperidines
MONOAMINE OXIDASE INHIBITORS; PIPERIDINES; SCHIZOPHRENIA